| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |